Company intelligence / Profile preview

Cedrus Investments

Zurich, Switzerland

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Cedrus Investments is not a therapeutics developer, but an investment and advisory firm specializing in asset management, with deep activity in the life sciences/biotech sector, especially in cross-border investment, strategic advisory, and market expansion programs for biopharma companies entering China and Greater Asia.[1][2][6][12]

Industry: Investors

Partnerships

Xiuzheng Pharmaceutical Group[10]Beijing Dachao Biotechnology Co Ltd[6][12]Orexa (Switzerland)[6][11]Kadence Bio (Switzerland)[6][11]Hainan Leyun Biotechnology Co., Ltd.[12]

Beyond the preview

Go deeper on Cedrus Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cedrus Investments.

Explore the full profile